SECsense Logo

Cara Therapeutics, Inc. 8-K Report: Key Insights and Financial Metrics

$CARA
Form 8-K
Filed on: 2025-01-17
Source
Cara Therapeutics, Inc. 8-K Report: Key Insights and Financial Metrics

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Cara Therapeutics, Inc.
  • CIK Number: 0001346830
  • File Type: 8-K (a report of unscheduled material events or corporate changes)
  • SEC Central Index Key (CIK): 0001346830
  • IRS Employer Identification Number (EIN): 75-3175693
  • Address: 400 Atlantic Street, Suite 500, Stamford, CT 06901
  • Phone Number: 203-406-3700
  1. Report Date:
  • Filing Date: January 14, 2025
  1. Stock Information:
  • Common Stock: Par value of $0.001 per share
  • Ticker Symbol: CARA
  • Exchange: NASDAQ
  1. Financial Metrics:
  • The report pertains to financial metrics denominated in USD (United States Dollars) and shares.
  • The report context suggests it covers data as of January 14, 2025.
  1. Regulatory Compliance:
  • The filing adheres to XBRL (eXtensible Business Reporting Language) format, which is a requirement for SEC filings, indicating that the data is structured for easy analysis and interoperability.
  1. Schema Reference:
  • The document references a schema file (cara-20250114.xsd), indicating the specific structure and definitions used in this filing.

Overall, the filing provides essential corporate information, regulatory compliance details, and stock-related data for Cara Therapeutics, Inc., relevant to investors and stakeholders monitoring the company's performance.